4.4 Article

Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer

Journal

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
Volume 13, Issue 7, Pages 979-987

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/18715206113139990115

Keywords

Cryptotanshinone; tanshinones; cancer; cell proliferation; cell death; mTOR

Funding

  1. Nanjing University of Chinese Medicine [2011ZYX4-002]
  2. National Natural Science Foundation of China [30801545, 81173174, 21162009]
  3. Jiangsu Natural Science Foundation [BK2012854]
  4. NIH [CA115414]
  5. American Cancer Society [RSG-08-135-01-CNE]

Ask authors/readers for more resources

Cryptotanshinone is one of the major tanshinones isolated from the roots of the plant Salvia miltiorrhiza Bunge (Danshen). Danshen has been widely used in traditional Chinese medicine for treatment of a variety of diseases, including coronary artery disease, acute ischemic stroke, hyperlipidemia, chronic renal failure, chronic hepatitis, and Alzheimer's disease, showing no serious adverse effects. Recent studies have shown that cryptotanshinone not only possesses the potential for treatment and prevention of the above-mentioned diseases, but also is a potent anticancer agent. Here we briefly summarize the physical and chemical properties and the pharmacokinetic profiles of cryptotanshinone, and then comprehensively review its anticancer activities as well as the underlying mechanisms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available